Print ArticleAffymetrix Inc. and ParAllele BioScience Inc., today announced the recent launch of a broad line of MegAllele(TM) assays for targeted single nucleotide polymorphism (SNP) genotyping applications. Co-developed during a two-year collaboration between the two companies, the assay products work with Affymetrix' industry standard GeneChip(R) Scanner (GCS) 3000 System with a newly available MegAllele four-color capability, to easily and cost- effectively genotype panels containing up to 10,000 custom or pre-defined SNPs. As announced on May 31, Affymetrix has entered into a definitive agreement to acquire ParAllele. The acquisition is expected to close in the third quarter of 2005.
The highly flexible assays offer researchers the ability to focus on specific regions of the genome more quickly and in greater detail than ever before. By leveraging the highly multiplexed MegAllele assay, scientists are able to generate more data per experiment at a more cost-effective rate.
"The new GCS 3000 MegAllele System provides scientists with the freedom to design virtually any experiment they want using either custom or off-the-shelf assays," said Greg Yap, Vice President of DNA Products, Affymetrix. "Our recent agreement to acquire ParAllele will help us better serve our customers by accelerating the rate at which we deliver new products to market and driving innovative assay development."
SOURCE: Affymetrix, Inc.
Mail to a Friend
Link to this article
